Industry drives low uptake for EU-US parallel advice
This article was originally published in SRA
Executive Summary
The future of the parallel scientific advice pilot launched between the US and the European Union several years ago is “a never ending debate”, according to the European Medicines Agency’s senior medical officer. Inevitably, the status of the ailing programme was brought up during a Q&A session at the Drug Information Association’s 45th annual meeting held in San Diego, US, on 21-25 June.
You may also be interested in...
Global medtech alliance approves six new member associations
An emerging alliance of medical technology industry associations representing innovative companies that currently develop and manufacture 85% of the world's medical devices, diagnostics and equipment has approved the membership applications of six more associations, bringing the total number of members to 19.
Global medtech alliance approves six new member associations
An emerging alliance of medical technology industry associations representing innovative companies that currently develop and manufacture 85% of the world's medical devices, diagnostics and equipment has approved the membership applications of six more associations, bringing the total number of members to 19.
US FDA scrutiny of DTC genetic tests continues
The US FDA's devices unit has written to three genetic testing companies warning them that they may be marketing their products and services without clearance by the agency.